Diagnosis and treatment of a child with the syndrome of apparent mineralocorticoid excess type

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 1, 1996, Pages 111-113

  Muller Berghaus J ^a   Homoki, J ^b   Michalk, D V ^a   Querfeld, U ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Hypertension; Nephrocalcinosis; Syndrome of apparent mineralocorticoid excess

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID; SPIRONOLACTONE;

APPARENT MINERALOCORTICOID EXCESS SYNDROME; ARTICLE; CASE REPORT; ENZYME ACTIVITY; HUMAN; HYPERTENSION; KIDNEY CALCIFICATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SYNDROME DELINEATION; URINARY EXCRETION;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ALDOSTERONE ANTAGONISTS; FAILURE TO THRIVE; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; INFANT; INFANT, NEWBORN; KIDNEY CALCULI; MALE; MINERALOCORTICOIDS; PREGNANCY; SPIRONOLACTONE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; URINE;

EID: 0030041469     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb13903.x     Document Type: Article

References (16)

1. Werder E, Zachmann M, Völlmin JA, Veyrat R, Prader A. Unusual steroid excretion in a child with low-renin hypertension. Res Steroid 1975:385-95
2. New MI, Levine LS, Biglieri EG, Pareira J, Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 1977;44:924-33
3. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979;49:757-64
4. Bournot M, Pitoizet N, Zachmann M, Maume BF. Partial characterization of unusual polar steroids in the urine of a child with low renin hypertension. J Steroid Biochem 1982;16:467-77
5. Oberfield SE, Levine LS, Carey RM, Greig F, Ulick S, New MI. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1983;56:332-9
6. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987;237:268-75
7. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, et al. Localisation of 11β-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 1988;ii:986-9
8. Honour JW, Dillon MJ, Levin M, Shah V. Fatal, low renin hypertension associated with a disturbance of cortisol metabolism. Arch Dis Child 1983;58:1018-20
9. Ulick S, Chan CK, Rao KN, Edassery J, Mantero F. A new form of the syndrome of apparent mineralocorticoid excess. J Steroid Biochem 1989;32:209-12
10. Ulick S, Tedde R, Wang JZ. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1992;74:593-9
11. Shackleton CHL, Rodriguez J, Arteaga E, Lopez JM, Winter JSD. Congenital 11β-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. J Clin Endocrinol Metab 1985;22:701-12
12. Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 1983;80:6056-60
13. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988;242:583-5
14. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CHL, Edwards CRW. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987;ii:821-4
15. Nikkilä H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, et al. Defects in the HSD11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J Clin Endocrinol Melab 1993;77:687-91
16. Batista MC, Mendonca BB, Kater CE, Arnold IJP, Rocha A, Nicolau W, et al. Spironolactone-reversible rickets associated with 11β-hydroxysteroid dehydrogenase deficiency syndrome. J Pediatr 1986;109:989-93